Ensign Peak Advisors, Inc
Position in TARS — Tarsus Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,911,726
-$6,446,961 QoQ
Shares Held
268,696
-19.3% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#40
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. TARS ranks #22 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,911,726 | 268,696 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,358,687 | 332,982 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $38,815,214 | 474,050 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $28,666,892 | 482,364 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $19,740,928 | 487,310 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,033,114 | 487,310 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $31,564,000 | 570,056 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,307,416 | 587,030 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,153,753 | 594,325 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $26,458,837 | 727,891 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,867,292 | 437,891 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,781,323 | 437,891 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,381,089 | 242,451 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,047,609 | 242,451 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,554,331 | 242,451 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,150,761 | 242,451 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,539,784 | 242,451 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,078,025 | 242,451 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,455,147 | 242,451 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,310,000 | 200,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,796,000 | 200,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,446,000 | 200,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,266,000 | 200,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||